Qbic Fund
VC Fund
Belgium, United States
Qbic Fund is a VC fund in Belgium focused on Biotechnology and Software. The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.
- Total investments:
- 62
- Last investment:
- Lead investor:
- 31%
- Fund size:
- $54M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Qbic Fund invests in
Stages Qbic Fund invests in
Countries Qbic Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.3M–$7.4M
- Series A
- $1.6M–$34M
Investment Focus
Industry
- Biotechnology 10 (16%)
- Software 7 (11%)
- Health Care 7 (11%)
- Medical 4 (6%)
- Information Technology 4 (6%)
Stage
- Seed 16 (26%)
- Funding Round 11 (18%)
- Series A 8 (13%)
- Series B 4 (6%)
- Pre-Seed 2 (3%)
Country
- Belgium 31 (50%)
- The Netherlands 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Sofie Baeten
CEO
|
CEO | Total investments: 4 | Find email | |
Cedric Van Nevel
Investment Manager
|
Investment Manager | Total investments: 7 | Find email | |
Danny Gonnissen
Venture Capital Fund Manager
|
Venture Capital Fund Manager | Total investments: 2 | Find email | |
Steven Leuridan
Partner
|
Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sightera Biosciences
|
Sightera Biosciences is a Biotechnology Research company. | $3.4M / Pre-Seed / Jul 17, 2026 | |
Eyeo
|
Eyeo is fundamentally redefining image sensing by eliminating decades-old limitations, Capturing all incoming light and drastically improving resolution. | $47M / Series A / May 11, 2026 | |
Firecell
|
Firecell is a Telecommunications Industry. | $9.4M / Venture - Series Unknown / Feb 18, 2026 | |
AILOS Robotics
|
AILOS Robotics develops advanced gearboxes and actuation systems to improve precision, efficiency, and versatility in human-centric robotic systems. | $4.1M / Seed / Dec 02, 2025 | |
Animab
|
Animal Health Company | $11.8M / Series B / Jul 01, 2025 | |
Spica Therapeutics
|
Spica Therapeutics is a biotech company to transform macrophage biology into breakthrough therapies for patients. | $11.4M / Seed / Jun 04, 2025 | |
|
Eyeo
|
Eyeo is fundamentally redefining image sensing by eliminating decades-old limitations, Capturing all incoming light and drastically improving resolution. | $17M / Seed / May 07, 2025 | |
Rainbow Crops
|
Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties. | Seed / Apr 29, 2025 | |
Aloxy
|
Aloxy provides an industrial internet of things solution for monitoring manual valve position in the industry. The company's services include valve position monitoring, emergency showers, line blinds, device management, network monitoring, and data integrity. Aloxy provides dependable industrial Internet of Things solutions designed to meetthe demands of the process industries, including chemical, oil, and gas, and others. | $8.1M / Mar 11, 2025 | |
Pleevi
|
Pleevi focuses on optimizing EV charging solutions for large parking facilities. It offers an AI-powered software solution that intelligently schedules charging sessions. The system considers local energy generation, pricing, and building load constraints, delivering cheaper and greener charging sessions while ensuring drivers comfort. Drivers canbe confident that their vehicles will be fully charged by the time they are ready to depart. | $1M / Pre-Seed / Jan 30, 2025 | |
| See all 62 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Qbic Fund invest in?
Qbic Fund invests primarily in Biotechnology, Software and Health Care startups, most often at Seed and Funding Round stage. Most of the 62 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Qbic Fund's check size?
Qbic Fund typically joins rounds of $1.3M–$7.4M at Seed and $1.6M–$34M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Qbic Fund participates in.
How do I contact Qbic Fund?
Public channels for Qbic Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Qbic Fund?
The team at Qbic Fund includes Sofie Baeten (CEO), Cedric Van Nevel (Investment Manager) and Danny Gonnissen (Venture Capital Fund Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
